Showing results (301-310 of 5,649) with videos related to

Sort By:
Pageof 565
Drug Design, Development and Therapy|January 16, 2019
A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat modelYejin Yang, Wooseong Kim, Dayoon Kim, et al.
Drug Design, Development and Therapy|February 2, 2019
Development of dual delivery antituberculotic system containing rifapentine microspheres and adipose stem cells seeded in hydroxyapatite/tricalcium phosphateQiuzhen Liang, Xinghua Song, Shengli She, et al.
Drug Design, Development and Therapy|December 1, 2018
Asiatic acid protests against myocardial ischemia/reperfusion injury via modulation of glycometabolism in rat cardiomyocyteYang Dai, Ziwei Wang, Minxue Quan, et al.
Drug Design, Development and Therapy|December 19, 2019
Catalpol Enhances Neurogenesis And Inhibits Apoptosis Of New Neurons Via BDNF, But Not The BDNF/Trkb PathwayHui-Feng Zhu, Yali Shao, Lei Qin, et al.
Drug Design, Development and Therapy|December 19, 2019
Erratum: A Novel Hybrid Compound LLP2A-Alendronate Accelerates Open Fracture Healing in a Rabbit Model [Corrigendum]
Drug Design, Development and Therapy|December 19, 2019
Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition StudiesAshfaq Ahmad, Farhat Ullah, Abdul Sadiq, et al.
Drug Design, Development and Therapy|December 19, 2019
In Silico, Cytotoxic and Antioxidant Potential of Novel Ester, 3-hydroxyoctyl -5- trans-docosenoate Isolated from Anchusa arvensis (L.) M.Bieb. Against HepG-2 Cancer CellsSajid Hussain, Farhat Ullah, Muhammad Ayaz, et al.
Drug Design, Development and Therapy|December 19, 2019
Drug-Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In RatsQiong Wang, Haiyun Wang, Youyan Zhong, et al.
Drug Design, Development and Therapy|December 19, 2019
Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and NilotinibDespoina Pantazi, Nikoleta Ntemou, Alexios Brentas, et al.
Drug Design, Development and Therapy|December 17, 2019
An Optimized Surfactant-Based PEG-PLCL In Situ Gel Formulation For Enhanced Activity Of Rosuvastatin In Poloxamer-Induced Hyperlipidemic RatsTarek A Ahmed, Mohammed A Mussari, Seham El-Sayed Abdel-Hady, et al.
Pageof 565